Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM6FSUW)

Drug Name

5-oxo-C20:3 Drug Info

Synonyms

5-oxo-6e,8z,11z-eicosatrienoic acid; 5-oxo-ETrE

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Oxoeicosanoid receptor 1 (OXER1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
5S-HETE	DM3Z6G4	Discovery agent	N.A.	Investigative	[3]
5S-HPETE	DME1304	Discovery agent	N.A.	Investigative	[3]
5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid	DM0K7U5	Discovery agent	N.A.	Investigative	[4]
5-oxo-12-HETE	DMLABR9	Discovery agent	N.A.	Investigative	[5]
5-oxo-15-HETE	DM9ZC7B	Discovery agent	N.A.	Investigative	[6]
Gue1654	DM89KNT	Discovery agent	N.A.	Investigative	[7]
[3H]5-oxo-ETE	DM50WFM	Discovery agent	N.A.	Investigative	[8]
5-oxo-ODE	DM56TVA	Discovery agent	N.A.	Investigative	[9]
5-oxo-20-HETE	DM493GU	Discovery agent	N.A.	Investigative	[6]
------------------------------------------------------------------------------------


⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Oxoeicosanoid receptor 1 (OXER1)	TT7WBSV	OXER1_HUMAN	Agonist	[2]

------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3392).
2	Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. J Pharmacol Exp Ther. 2008 May;325(2):698-707.
3	TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis. Biochem Biophys Res Commun. 2005 Sep 9;334(4):987-95.
4	5-Oxo-ETE receptor antagonists. J Med Chem. 2013 May 9;56(9):3725-32.
5	Biological inactivation of 5-oxo-6,8,11,14-eicosatetraenoic acid by human platelets. Blood. 1999 Feb 1;93(3):1086-96.
6	Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils. J Immunol. 1996 Jan 1;156(1):336-42.
7	A biased ligand for OXE-R uncouples Galpha and Gbetagamma signaling within a heterotrimer. Nat Chem Biol. 2012 Jul;8(7):631-8.
8	Receptors for the 5-oxo class of eicosanoids in neutrophils. J Biol Chem. 1998 Dec 4;273(49):32535-41.
9	Human neutrophils convert the sebum-derived polyunsaturated fatty acid Sebaleic acid to a potent granulocyte chemoattractant. J Biol Chem. 2008 Apr 25;283(17):11234-43.